The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEGLEA BIOTHERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 4,635,657 | 378,421 | SH | SOLE | 378,421 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | BBG01H51WYQ5 | 62,647,049 | 2,941,176 | SH | SOLE | 2,941,176 | 0 | 0 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | BBG00GHB88X9 | 41,172,538 | 83,747 | SH | SOLE | 83,747 | 0 | 0 | ||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 14,184,422 | 1,901,397 | SH | SOLE | 1,901,397 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | BBG00B6G7GL7 | 163,629,124 | 2,341,238 | SH | SOLE | 2,341,238 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHZQR7 | 34,700,006 | 3,558,975 | SH | SOLE | 3,558,975 | 0 | 0 | ||
| DBV TECHNOLOGIES SA | SPONSORED ADR | 23306J101 | BBG0076D3T39 | 9,222,364 | 6,781,150 | SH | SOLE | 6,781,150 | 0 | 0 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | BBG00FB2NPZ0 | 26,362,636 | 1,928,503 | SH | SOLE | 1,928,503 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 29,114,501 | 2,131,369 | SH | SOLE | 2,131,369 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | BBG000C2JTB5 | 94,102,625 | 5,929,592 | SH | SOLE | 5,929,592 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 28,792,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | BBG00KT2KFX7 | 42,983,125 | 2,474,561 | SH | SOLE | 2,474,561 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 44,362,115 | 1,881,345 | SH | SOLE | 1,881,345 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | BBG00Z1SLMK5 | 112,710,119 | 2,451,819 | SH | SOLE | 2,451,819 | 0 | 0 | ||
| RAYZEBIO INC | COM | 75525N107 | BBG00XV9FHD5 | 27,126,269 | 1,221,904 | SH | SOLE | 1,221,904 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | BBG0024L5B86 | 33,714,378 | 1,142,473 | SH | SOLE | 1,142,473 | 0 | 0 | ||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | BBG00KK1SJ08 | 10,261,200 | 2,040,000 | SH | SOLE | 2,040,000 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | BBG003QGQRB9 | 11,255,966 | 5,163,287 | SH | SOLE | 5,163,287 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | BBG00RCQD9D1 | 19,186,140 | 1,393,329 | SH | SOLE | 1,393,329 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H242Z5 | 21,010,017 | 1,369,623 | SH | SOLE | 1,369,623 | 0 | 0 | ||